fig1

Systemic delivery of large-scale manufactured Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction

Figure 1. WJMSC expansion and EV manufacturing in the quantum bioreactor. (A) Recorded values of the daily lactate production during WJMSC expansion. (B) The daily prediction of cell numbers within the bioreactor. (C) The average number of EVs isolated at each collection point. (D) The average total number of EVs collected in a single bioreactor run. (E) The average mode size of the EV harvest at each collection time point. (F) The average mode size of the EVs isolated from a single bioreactor run. *P < 0.05, ***P < 0.001. WJMSC: Wharton’s Jelly-derived mesenchymal stem cell; EVs: extracellular vesicles; PLT: human platelet lysate; FBS: fetal bovine serum.

The Journal of Cardiovascular Aging

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/